Viking Global Investors

Holding/activity history for  Kinnate Biopharma Inc. (KNTE-OLD)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q4 1,820,462 0.02 $2.37
2023   Q3 1,820,462 0.01 $1.40
2023   Q2 1,820,462 0.02 $3.03
2023   Q1 1,820,462 0.05 $6.25
2022   Q4 1,820,462 0.06 $6.10
2022   Q3 1,820,462 0.10 $11.95
2022   Q2 1,820,462 0.11 $12.61
2022   Q1 1,820,462 0.08 $11.26
2021   Q4 1,820,462 0.09 $17.72
2021   Q3 1,820,462 0.12 $23.02
2021   Q2 1,820,462 0.13 Reduce 2.75% 0.00 $23.28
2021   Q1 1,872,023 0.17 $31.16
2020   Q4 1,872,023 0.20 Buy 0.20 $39.78